ctDNA for Minimal Disease Research by Hybridization Capture in Resected Cancer Samples
Integrated DNA Technologies (IDT) via YouTube
Power BI Fundamentals - Create visualizations and dashboards from scratch
Live Online Classes in Design, Coding & AI — Small Classes, Free Retakes
Overview
Google, IBM & Meta Certificates – 40% Off
One plan covers every Professional Certificate on Coursera.
Unlock All Certificates
Explore how hybridization capture solutions are revolutionizing circulating tumor DNA (ctDNA) research for minimal residual disease (MRD) in this 17-minute webinar by Integrated DNA Technologies (IDT). Gain valuable insights into the significance of MRD research, its advantages over traditional methods, and its role in discovering new biomarkers. Understand how IDT's technology is helping researchers overcome challenges in ctDNA analysis for resected cancer samples. Discover the potential for new collaborations and breakthroughs in oncology research as these innovative studies are brought to the forefront. For more information, visit https://idtb.io/bmru7r.
Syllabus
ctDNA for minimal disease research by hybridization capture in resected cancer samples
Taught by
Integrated DNA Technologies (IDT)